Long-term stability of procalcitonin in frozen samples and comparison of Kryptor® and VIDAS® automated immunoassays

Clinical Biochemistry

Volumn 43, Issue 3, 2010, Pages 341-344

  Schuetz, Philipp ^a   Christ Crain, Mirjam ^a   Huber, Andreas R ^b   Müller, Beat ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b CANTONAL HOSPITAL AARAU   (Switzerland)

Author keywords

Method comparison; Procalcitonin; Respiratory tract infections; Sample stability

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN;

ARTICLE; CONTROLLED STUDY; FREEZING; HORMONE DETERMINATION; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LABORATORY AUTOMATION; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN STABILITY; REFERENCE VALUE; STORAGE;

BIOLOGICAL MARKERS; CALCITONIN; CRYOPRESERVATION; HUMANS; IMMUNOASSAY; PROTEIN PRECURSORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REFERENCE VALUES; SPECIMEN HANDLING;

EID: 74249119968     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.08.029     Document Type: Article

References (17)

1. Schuetz P., Christ-Crain M., and Muller B. Biomarkers to improve diagnostic and prognostic accuracy in systemic infections. Curr. Opin. Crit. Care 13 (2007) 578-585
2. Schuetz P., Christ-Crain M., and Muller B. Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections-hope for hype?. Swiss Med. Wkly. 139 (2009) 318-326
3. Snider Jr. R.H., Nylen E.S., and Becker K.L. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization. J. Investig. Med. 45 (1997) 552-560
4. Stolz D., Christ-Crain M., Bingisser R., et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 131 (2007) 9-19
5. Schuetz P., Christ-Crain M., Wolbers M., et al. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial. B.M.C. Health Serv. Res. 7 (2007) 102
6. Christ-Crain M., Stolz D., Bingisser R., et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am. J. Respir. Crit. Care Med. 174 (2006) 84-93
7. Christ-Crain M., Jaccard-Stolz D., Bingisser R., et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363 (2004) 600-607
8. Briel M., Schuetz P., Mueller B., et al. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch. Intern. Med. 168 (2008) 2000-2007 discussion 7-8
9. Nobre V., Harbarth S., Graf J.D., Rohner P., and Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am. J. Respir. Crit. Care Med. 177 (2008) 498-505
10. Steinbach G., Rau B., Debard A.L., et al. Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor System. Clin. Chem. Lab. Med. 42 (2004) 440-449
11. Hubl W., Krassler J., Zingler C., et al. Evaluation of a fully automated procalcitonin chemiluminescence immunoassay. Clin. Lab. 49 (2003) 319-327
12. de Wolf H.K., Gunnewiek J.K., Berk Y., van den Ouweland J., and de Metz M. Comparison of a new procalcitonin assay from Roche with the established method on the Brahms Kryptor. Clin. Chem. 55 (2009) 1043-1044
13. Bablok W., Passing H., Bender R., and Schneider B. A general regression procedure for method transformation. Application of linear regression procedures for method comparison studies in clinical chemistry, Part III. J. Clin. Chem. Clin. Biochem. 26 (1988) 783-790
14. Dewitte K., Fierens C., Stockl D., and Thienpont L.M. Application of the Bland-Altman plot for interpretation of method-comparison studies: a critical investigation of its practice. Clin. Chem. 48 (2002) 799-801 author reply -2
15. Masia M., Gutierrez F., Shum C., et al. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index. Chest 128 (2005) 2223-2229
16. Barassi A., Pallotti F., and Melzi d'Eril G. Biological variation of procalcitonin in healthy individuals. Clin. Chem. 50 (2004) 1878
17. Schuetz P., Christ-Crain M., Thomann R., et al. A Procalcitonin Algorithm versus a Clinical Guideline Algorithm for Antibiotic Treatment in Lower Respiratory Tract Infections: The Randomized-controlled Multicenter ProHOSP Trial. JAMA 302 10 (2009) 1059-1066